About Us

Denichiro “Denny” Otsuga, PhD, COO and Co-Founder

Denny is an experienced business executive and entrepreneur. Denny was the co-founder of a boutique intellectual property management consulting firm, which a publicly traded company subsequently acquired.  Denny holds a PhD in plant molecular genetics and worked in a biotechnology startup bridging science and business operations. Additionally, Denny has worked in venture capital and management consulting firms specializing in DeepTech startups. He has also held senior management positions in several universities, overseeing intellectual property licensing and technology-based venture startup operations.

Dr. Anthony Brockway, Vice President of Chemistry

A.J. holds both a B.S. in Chemistry and a PhD. in Chemistry from the University of California, Davis. He has more than 17 years of experience as a synthetic organic chemist in areas spanning organic reaction methodology development, natural product total synthesis, polymer chemistry, polymer drug conjugation, and medicinal chemistry. He performed postdoctoral research in medicinal chemistry at the University of Texas Southwestern Medical Center in Dallas, TX prior to beginning his industrial career as a medicinal chemist in the biotechnology sector. He worked as a synthetic medicinal chemist for Nektar Therapeutics in San Francisco, CA for more than six years before joining Pfizer in Boulder, CO for more than one year. He joined Sust-Chem in April 2024 and is excited to develop Sust-Chem’s platform to deliver sustainable solutions to the worldwide plastic crisis. He is a co-author on seven peer-reviewed publications and is a co-inventor on one patent.

Ryan Anderson, Principal Chemist

Ryan received his MS in Organic Chemistry at Colorado State University and BA in Chemistry at North Carolina State University. With almost 10 years of experience performing synthetic organic chemistry research, Ryan has a proven track record of success, appearing on three peer-reviewed publications and five patents. He’s contributed to many significant R&D initiatives, including discovering and scaling-up the API at Vast Therapeutics, a startup biotech company, which resulted in achieving IND regulatory approval. Most recently, he worked as a medicinal chemist at Pfizer Boulder R&D for three years in oncology drug discovery. He joined Sust-Chem in October 2024 with a desire to bring innovative and sustainable solutions to the global plastic waste crisis.

Dr. Alan Dyke, Board of Advisors

Alan received his MSci and PhD in Organic Chemistry the University of Bristol. He has many experiences including serving as Vice President of Business Development at ProChem Inc. He oversees the commercial operations of ProChem, a leading supplier of high purity inorganic compounds and custom precursors for advanced materials applications. He also supports the new investments in laboratories, analytical services, and management systems. Alan is also a Senior Advisor for Saoradh Enterprise Partners and is on the Board of Governors at the Society of Chemical Manufacturers & Affiliates® (SOCMA).